99 related articles for article (PubMed ID: 1522353)
21. The "primary" antiphospholipid syndrome: major clinical and serological features.
Asherson RA; Khamashta MA; Ordi-Ros J; Derksen RH; Machin SJ; Barquinero J; Outt HH; Harris EN; Vilardell-Torres M; Hughes GR
Medicine (Baltimore); 1989 Nov; 68(6):366-74. PubMed ID: 2509856
[TBL] [Abstract][Full Text] [Related]
22. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
[TBL] [Abstract][Full Text] [Related]
23. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome.
Lopez LR; Dier KJ; Lopez D; Merrill JT; Fink CA
Am J Clin Pathol; 2004 Jan; 121(1):142-9. PubMed ID: 14750252
[TBL] [Abstract][Full Text] [Related]
24. Distribution of lupus anticoagulant and anticardiolipin antibody isotypes in a population with antiphospholipid syndrome.
Guglielmone HA; Fernandez EJ
J Rheumatol; 1999 Jan; 26(1):86-90. PubMed ID: 9918246
[TBL] [Abstract][Full Text] [Related]
25. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
Swadzba J; De Clerck LS; Stevens WJ; Bridts CH; van Cotthem KA; Musial J; Jankowski M; Szczeklik A
J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
[TBL] [Abstract][Full Text] [Related]
26. Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies.
Lavalle C; Pizarro S; Drenkard C; Sánchez-Guerrero J; Alarcón-Segovia D
J Rheumatol; 1990 Jan; 17(1):34-7. PubMed ID: 2313670
[TBL] [Abstract][Full Text] [Related]
27. [Clinical analysis of 61 patients with antiphospholipid syndrome].
Leng XM; Liu XM; Ai MX; Zeng XF; Tang FL
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1367-70. PubMed ID: 15387947
[TBL] [Abstract][Full Text] [Related]
28. Comparison between the standard anticardiolipin antibody test and a new phospholipid test in patients with connective tissue diseases.
Merkel PA; Chang Y; Pierangeli SS; Harris EN; Polisson RP
J Rheumatol; 1999 Mar; 26(3):591-6. PubMed ID: 10090168
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Cervera R; Espinosa G; Carmona F; Balasch J; Ordinas A; Ingelmo M
Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121
[TBL] [Abstract][Full Text] [Related]
30. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
[TBL] [Abstract][Full Text] [Related]
31. The association of antibodies to cardiolipin, beta 2-glycoprotein I, prothrombin, and oxidized low-density lipoprotein with thrombosis in 292 patients with familial and sporadic systemic lupus erythematosus.
Koskenmies S; Vaarala O; Widen E; Kere J; Palosuo T; Julkunen H
Scand J Rheumatol; 2004; 33(4):246-52. PubMed ID: 15370721
[TBL] [Abstract][Full Text] [Related]
32. Anticardiolipin antibodies in acquired immunodeficiency syndrome.
Stimmler MM; Quismorio FP; McGehee WG; Boylen T; Sharma OP
Arch Intern Med; 1989 Aug; 149(8):1833-5. PubMed ID: 2504122
[TBL] [Abstract][Full Text] [Related]
33. [Retinal vascular lesions in systemic lupus erythematosus and secondary antiphospholipid syndrome].
Ermakova NA; Alekberova ZS; Reshetniak TM; Kalashnikova LA; Kosheleva NM
Vestn Oftalmol; 2005; 121(5):31-6. PubMed ID: 16274063
[TBL] [Abstract][Full Text] [Related]
34. Significance of antiphospholipid antibodies in lupus nephritis.
Natejumnong C; Ruangkanchanasetr P; Aimpun P; Supaporn T
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S121-8. PubMed ID: 17044463
[TBL] [Abstract][Full Text] [Related]
35. Longitudinal determination of antiphospholipid antibodies in lupus patients without previous manifestations of antiphospholipid syndrome. A prospective study.
de Bandt M; Benali K; Guillevin L; Hachulla E; Job C; Fautrel B; Fournié G; Bonnet C; Fournié B; Le Goff P; Jorgensen C; Meyer O
J Rheumatol; 1999 Jan; 26(1):91-6. PubMed ID: 9918247
[TBL] [Abstract][Full Text] [Related]
36. Detection of complement-fixing antiphospholipid antibodies in association with thrombosis.
Munakata Y; Saito T; Matsuda K; Seino J; Shibata S; Sasaki T
Thromb Haemost; 2000 May; 83(5):728-31. PubMed ID: 10823270
[TBL] [Abstract][Full Text] [Related]
37. Lupus-like anticoagulants and lower extremity arterial occlusive disease.
Eldrup-Jorgensen J; Brace L; Flanigan DP; Schwarcz TH; Fritsma G; Meyer JP; Schuler JJ
Circulation; 1989 Nov; 80(5 Pt 2):III54-8. PubMed ID: 2509107
[TBL] [Abstract][Full Text] [Related]
38. [Comparative analysis of clinical and laboratory charactiristics of antiphospholipid syndrome].
Soltész P; Veres K; Kiss E; Lakos G; Sonkoly I; Muszbek L; Szegedi G
Orv Hetil; 2000 Dec; 141(52):2821-5. PubMed ID: 11202118
[TBL] [Abstract][Full Text] [Related]
39. Variability of anticardiolipin antibody isotype distribution in 3 geographic populations of patients with systemic lupus erythematosus.
Molina JF; Gutierrez-Ureña S; Molina J; Uribe O; Richards S; De Ceulaer C; Garcia C; Wilson WA; Gharavi AE; Espinoza LR
J Rheumatol; 1997 Feb; 24(2):291-6. PubMed ID: 9034985
[TBL] [Abstract][Full Text] [Related]
40. The prevalence of antiphospholipid antibody syndrome among systemic lupus erythematosus patients.
McMahon MA; Keogan M; O'Connell P; Kearns G
Ir Med J; 2006; 99(10):296-8. PubMed ID: 17274170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]